JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.23, no.9, pp.885-889, 2010 (SCI-Expanded)
Background: Growth hormone (GH), insulin-like growth factor-1 (IGF-1), and IGF-binding protein-3 (IGFBP-3) are used in the neonatal period for evaluation of diseases such as GH deficiency, intrauterine growth restriction, and hypoglycemia. However, GH level has been reported as a single value during the neonatal period. In this study, we attempted to determine the changes of GH, IGF-1, and IGFBP-3 in the neonatal period for each week.